Related Experiment Videos
PMP22 accumulation in aggresomes: implications for CMT1A pathology
L Notterpek1, M C Ryan, A R Tobler
1Department of Neurobiology, Stanford University School of Medicine, Stanford, California, 94305, USA. notterp@ufbi.ufl.edu
Neurobiology of Disease
|October 21, 1999
Summary
The proteasome pathway is crucial for regulating peripheral myelin protein 22 (PMP22) levels in Schwann cells. Impaired proteasome function leads to PMP22 accumulation, potentially contributing to peripheral neuropathies.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Peripheral myelin protein 22 (PMP22) is vital for Schwann cell function.
- Gene copy number variations of PMP22 are linked to hereditary peripheral neuropathies.
- Most newly synthesized PMP22 in Schwann cells undergoes rapid degradation, likely due to misfolding.
Purpose of the Study:
- To investigate the degradation pathway of PMP22 in Schwann cells.
- To explore the role of the proteasome in PMP22 regulation.
- To determine if PMP22 accumulation contributes to peripheral neuropathy pathogenesis.
Main Methods:
- Inhibition of the proteasome pathway in Schwann cells.
- Overexpression of PMP22 in Schwann cells.
- Double immunolabeling with anti-ubiquitin and organelle markers.
Main Results:
- Proteasome inhibition caused significant PMP22 accumulation in the perinuclear cytoplasm.
- Accumulated PMP22 formed intracellular inclusions identified as aggresomes.
- PMP22 overexpression induced perinuclear accumulation.
Conclusions:
- The proteasome pathway is essential for controlling PMP22 protein levels.
- Aggresomes may play a role in the development of PMP22-related peripheral neuropathies.
- Understanding PMP22 regulation offers insights into hereditary neuropathies.